Cargando…

Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553

Detalles Bibliográficos
Autores principales: Graziosi, Luigina, Natalizi, Nicola, Donini, Annibale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303780/
https://www.ncbi.nlm.nih.gov/pubmed/37373963
http://dx.doi.org/10.3390/jpm13060974
_version_ 1785065356290686976
author Graziosi, Luigina
Natalizi, Nicola
Donini, Annibale
author_facet Graziosi, Luigina
Natalizi, Nicola
Donini, Annibale
author_sort Graziosi, Luigina
collection PubMed
description
format Online
Article
Text
id pubmed-10303780
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103037802023-06-29 Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553 Graziosi, Luigina Natalizi, Nicola Donini, Annibale J Pers Med Comment MDPI 2023-06-09 /pmc/articles/PMC10303780/ /pubmed/37373963 http://dx.doi.org/10.3390/jpm13060974 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Comment
Graziosi, Luigina
Natalizi, Nicola
Donini, Annibale
Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553
title Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553
title_full Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553
title_fullStr Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553
title_full_unstemmed Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553
title_short Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553
title_sort rationale in the use of adjuvant chemotherapy in pt3n0m0 gastric cancer resected patients. comment on chen et al. prognostic factors and the role of adjuvant chemotherapy in pathological node-negative t3 gastric cancer. j. pers. med. 2023, 13, 553
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303780/
https://www.ncbi.nlm.nih.gov/pubmed/37373963
http://dx.doi.org/10.3390/jpm13060974
work_keys_str_mv AT graziosiluigina rationaleintheuseofadjuvantchemotherapyinpt3n0m0gastriccancerresectedpatientscommentonchenetalprognosticfactorsandtheroleofadjuvantchemotherapyinpathologicalnodenegativet3gastriccancerjpersmed202313553
AT natalizinicola rationaleintheuseofadjuvantchemotherapyinpt3n0m0gastriccancerresectedpatientscommentonchenetalprognosticfactorsandtheroleofadjuvantchemotherapyinpathologicalnodenegativet3gastriccancerjpersmed202313553
AT doniniannibale rationaleintheuseofadjuvantchemotherapyinpt3n0m0gastriccancerresectedpatientscommentonchenetalprognosticfactorsandtheroleofadjuvantchemotherapyinpathologicalnodenegativet3gastriccancerjpersmed202313553